0000950123-11-034880.txt : 20110412 0000950123-11-034880.hdr.sgml : 20110412 20110412141911 ACCESSION NUMBER: 0000950123-11-034880 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110409 ITEM INFORMATION: Other Events FILED AS OF DATE: 20110412 DATE AS OF CHANGE: 20110412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0429 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 11754600 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PKWY CITY: MINNEAPOLIS STATE: MN ZIP: 55432 8-K 1 c64035e8vk.htm FORM 8-K e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 9, 2011
Medtronic, Inc.
(Exact name of Registrant as Specified in its Charter)
         
Minnesota
(State or other jurisdiction of
incorporation) 		  1-7707
(Commission File Number) 		  41-0793183
(IRS Employer Identification No.)
     
710 Medtronic Parkway Minneapolis, Minnesota
(Address of principal executive offices) 		  55432
(Zip Code)
(Registrant’s telephone number, including area code): (763) 514-4000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01.   Other Events.
The Conversion Rate (as defined in each of the Indentures by and between Medtronic, Inc. (“Medtronic”) and Wells Fargo Bank, N.A., as trustee, dated as of April 18, 2006) for Medtronic’s 1.50% Convertible Senior Notes due 2011 (the “2011 Notes”) was adjusted to 18.5175 shares of Common Stock per $1,000 principal amount of 2011 Notes, effective April 9, 2011. The Conversion Rate for Medtronic’s 1.625% Convertible Senior Notes due 2013 (the “2013 Notes” and together with the 2011 Notes, the “Notes”) will be adjusted to 18.5175 shares of Common Stock per $1,000 principal amount of 2013 Notes, effective April 18, 2011. The adjusted Conversion Rate reflects the cumulative impact of Medtronic’s payment of regular cash dividends since the issuance date of the Notes, and is being made on a carryforward basis under Section 10.14 of the applicable Indentures.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MEDTRONIC, INC.
 		  
  By /s/ Gary L. Ellis    
Date: April 12, 2011  Gary L. Ellis   
  Senior Vice President and Chief Financial Officer